Univar Czech s.r.o. acquires enzymes distribution business of Ekozym
Univar N.V. announced that its subsidiary Univar Czech s.r.o. in Prague has acquired the enzymes distribution business of Ekozym s.r.o., based in Vizovice, Czech Republic. This highly specialized business is based on the distribution of products from Novozymes A/S.
According to the company, this is another step towards Univar's ambitions to be a key player in Central and Eastern Europe. It will further expand Univar's activities serving the detergent, brewing, beverage alcohol and food markets in the Czech Republic, as well as strengthen the relationship with Novozymes.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Cheaper drugs, vaccines forecast as collaborations grow between developing countries' biotech firms - 'South-South' biotech collaborations boost health, economies: Study

Nanostructures in human teeth
Additional Data from Multiple Phase 1 and 2 Studies of S*BIO’s Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis - SB1518 Alleviates MF-Associated Splenomegaly and Shows No Myelosuppression and No Exacerbation of Cytopenias

Signs of dementia are written in the blood - 33 metabolic compounds linked to dementia could be key to new methods of diagnosis and treatment
Blood brain barrier gateway found
European Commision approves Amgen´s KINERET® for the treatment of rheumatoid arthritis - First Interleukin-1 receptor antagonist represents new way to treat RA
Evotec Enters into Long-Term Focused Library Agreement with Almirall - Value Exceeding EUR 2.5 m over the Two-Year Contract Period
Why gold nanoparticles can penetrate cell walls - Gold nanoparticles with special coatings can deliver drugs or biosensors to a cell's interior without damaging it
BAC signs license agreement with Hematech
